Page 40 - Pharma Services News Today

Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities...

Continuous manufacturing said to enable faster clinical and commercial pathways When it comes to continuous manufacturing, software challenges are greater than the hardware challenges faced in setting up a new manufacturing line, because at this time, due to a lack of standardization, debugging and validation can be significant components of the overall timeline, says an industry insider. Doug Hausner, senior manager, continuous manufacturing business development, ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Interpace Biosciences Announces First Quarter 2021 Financial and Business Results Interpace Biosciences, Inc.May 11, 2021 GMT   ● Q1 Revenue of $9.8 Million is Company’s Highest as Combined Molecular Diagnostics and Pharma Services Business       ADVERTISEMENT PARSIPPANY, NJ, May 11, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today...

12 Pharmaceutical logistics is a specialized branch of logistics services wherein service providers are focused on providing transporting, storage, proper handling and delivering the pharmaceutical products from the manufacturing location to the desired location. Pharmaceutical logistics require the services to be designated as per the regulations of products provided by the authorities. Competitive Analysis:  Global pharmaceutical logistics market is highly fragmented and the major players ...

Operator Good morning, ladies and gentlemen, and welcome to the NeoGenomics First Quarter 2021 Earnings Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, Doug Vianor. Sir, the floor is yours. Douglas M. VanOort -- Chairman of the Board of Directors and Executive Chairman Well, thank you, Holly, and good morning, everyone. Id like to welcome everyone to NeoGenomics First Quarter 2021 Conference Call. We have a lot of exciting news to share today. But first...

  Shares of NeoGenomics (NASDAQ:NEO) decreased 0.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share ...

First-Quarter 2021 Results and Highlights: Consolidated revenue increased 9% to $116 million Clinical Services revenue increased 4% to $96 million Pharma Services revenue increased 46% to $19 million Completed

NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter ACCESSWIRE First-Quarter 2021 Results and Highlights: Consolidated revenue increased 9% to $116 million Clinical Services revenue increased 4% to $96 million Pharma Services revenue increased 46% to $19 million Completed the acquisition of Trapelo Health in April FORT MYERS, FL / ACCESSWIRE / May 5, 2021 / NeoGenomics, Inc. (NASDAQ:NEO) (the Company ), a leading provider of cancer-focused genetics testing services, toda...

Neogenomics Inc (NEO) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Neogenomics Inc (NASDAQ: NEO) Operator Good morning, ladies and gentlemen, and welcome to the NeoGenomics First Quarter 2021 Earnings Call. [Operator Instructions] It is now my pleasure to turn the floor over to your host, Doug Vianor. Sir, the floor is yours.SPONSORED: 10 stocks we like better than NeoGenomics, Inc. When investing geniu...

04.29.21 -- COVID-19s Impact On Outsourced Small Molecule Manufacturing     Catching up to the paradigm shift in optimizing, scaling up, and manufacturing plasmids is crucial for clinical to commercial program success for gene therapies and vaccines. With an increased demand for plasmids for targeted gene therapeutic delivery, partnering with a CDMO equipped with the capacity, expertise, and equipment for plasmid DNA production is critical to ensuring a stabl...